Renal Proximal Tubule Cell Cannabinoid-1 Receptor Regulates Bone Remodeling and Mass via a Kidney-to-Bone Axis

Renal Proximal Tubule Cell Cannabinoid-1 Receptor Regulates Bone Remodeling and Mass via a Kidney-to-Bone Axis

The renal proximal tubule cells (RPTCs), well-known for maintaining glucose and mineral homeostasis, play a critical role in the regulation of kidney function and bone remodeling. Deterioration in RPTC function may therefore lead to the development of diabetic kidney disease (DKD) and osteoporosis....

Full description

Bibliographic Details
Main Authors:	Saja Baraghithy, Yael Soae, Dekel Assaf, Liad Hinden, Shiran Udi, Adi Drori, Yankel Gabet, Joseph Tam
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	Cells
Subjects:	type 1 diabetes osteoporosis CB1 receptor erythropoietin
Online Access:	https://www.mdpi.com/2073-4409/10/2/414

Similar Items

Classical cannabinoid receptors as target in cancer-induced bone pain: a systematic review, meta-analysis and bioinformatics validation
by: Feier Zeng, et al.
Published: (2024-03-01)

Evaluation of cannabinoid receptors type 1–2 in periodontitis patients
by: Atefe Ataei, et al.
Published: (2022-10-01)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
by: Zamzam Awida, et al.
Published: (2022-10-01)

Cannabinoid and Cannabinoid-Related Receptors in the Myenteric Plexus of the Porcine Ileum
by: Andrea Toschi, et al.
Published: (2021-01-01)

CB1R regulates soluble leptin receptor levels via CHOP, contributing to hepatic leptin resistance
by: Adi Drori, et al.
Published: (2020-11-01)

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
by: Giulia Abate, et al.
Published: (2021-06-01)

Erythropoietin Mediated Bone Loss in Mice Is Dose-Dependent and Mostly Irreversible
by: Albert Kolomansky, et al.
Published: (2020-05-01)

Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2
by: Bitya Raphael-Mizrahi, et al.
Published: (2022-05-01)

Cannabinoids: Emerging sleep modulator
by: Zhen Xuen Brandon Low, et al.
Published: (2023-09-01)

Cannabinoid Receptor Modulation of Neurogenesis: ST14A Striatal Neural Progenitor Cells as a Simplified In Vitro Model
by: Erika Cottone, et al.
Published: (2021-03-01)

Structure–Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074
by: George Amato, et al.
Published: (2022-09-01)

Pregnancy success in mice requires appropriate cannabinoid receptor signaling for primary decidua formation
by: Yingju Li, et al.
Published: (2020-09-01)

Cannabinoids and Their Receptors in Skin Diseases
by: Eun Hee Yoo, et al.
Published: (2023-11-01)

Cannabinoids and PPAR Ligands: The Future in Treatment of Polycystic Ovary Syndrome Women with Obesity and Reduced Fertility
by: Piotr Przybycień, et al.
Published: (2022-08-01)

Saturated Cannabinoids: Update on Synthesis Strategies and Biological Studies of These Emerging Cannabinoid Analogs
by: Maite L. Docampo-Palacios, et al.
Published: (2023-09-01)

Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023-08-01)

Cannabinoid CB1 Receptor Expression and Localization in the Dorsal Horn of Male and Female Rat and Human Spinal Cord
by: Jessica Parnell, et al.
Published: (2023-07-01)

Confound, Cause, or Cure: The Effect of Cannabinoids on HIV-Associated Neurological Sequelae
by: Alexander Starr, et al.
Published: (2021-06-01)

Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
by: Felix Marius Bläsius, et al.
Published: (2023-01-01)

Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products
by: Dongchen An, et al.
Published: (2020-07-01)

The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice
by: Zamzam Awida, et al.
Published: (2021-12-01)

A Robust and Efficient FRET-Based Assay for Cannabinoid Receptor Ligands Discovery
by: Gemma Navarro, et al.
Published: (2023-12-01)

<i>Cannabis</i>: From a Plant That Modulates Feeding Behaviors toward Developing Selective Inhibitors of the Peripheral Endocannabinoid System for the Treatment of Obesity and Metabolic Syndrome
by: Shira Hirsch, et al.
Published: (2019-05-01)

Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice
by: Claudia Gonzalo-Consuegra, et al.
Published: (2024-05-01)

Attenuation Effect of Cannabinoid Type 1 Receptor Activation on Methamphetamine-Induced Neurodegeneration and Locomotion Impairments among Male Rats
by: Effat Ramshini, et al.
Published: (2017-11-01)

Kidney Proximal Tubule GLUT2—More than Meets the Eye
by: Majdoleen Ahmad, et al.
Published: (2022-12-01)

The Role of Cannabinoids in Bone Metabolism: A New Perspective for Bone Disorders
by: Federica Saponaro, et al.
Published: (2021-11-01)

Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis
by: Roberto Chiocchetti, et al.
Published: (2022-09-01)

New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence
by: Rocio Saravia, et al.
Published: (2021-12-01)

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
by: Qing-Rong Liu, et al.
Published: (2020-12-01)

Effects of deleting cannabinoid receptor-2 on mechanical and material properties of cortical and trabecular bone
by: Aysha B. Khalid, et al.
Published: (2015-12-01)

Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats
by: Nafiseh Faraji, et al.
Published: (2017-03-01)

Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina
by: Sofia Papadogkonaki, et al.
Published: (2023-10-01)

Neuroprotective Effects of Cannabidiol but Not Δ<sup>9</sup>-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with <i>Cannabis</i> Extracts and Selected Cannabinoids
by: Elisa Landucci, et al.
Published: (2021-09-01)

Cannabis and cannabinoids as an alternative remedy in metabolic syndrome
by: Claudia Ali Montoya-Alatriste, et al.
Published: (2022-11-01)

Cannabinoids modulate associative cerebellar learning via alterations in behavioral state
by: Catarina Albergaria, et al.
Published: (2020-10-01)

Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB<sub>1</sub>/CB<sub>2</sub> Receptor Interaction
by: Battistina Asproni, et al.
Published: (2021-04-01)

Identification of an Orally Bioavailable, Brain-Penetrant Compound with Selectivity for the Cannabinoid Type 2 Receptor
by: Meirambek Ospanov, et al.
Published: (2022-01-01)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
by: Reem Smoum, et al.
Published: (2022-10-01)

Endocannabinoid System and Exogenous Cannabinoids in Depression and Anxiety: A Review
by: Ahmed Hasbi, et al.
Published: (2023-02-01)